Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer

References

• Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, et al. A national strategic change in treatment policy for rectal cancer – implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857–66.
   PubMed Web of Science ®Google Scholar
• Tveit KM, Dahl O, Gerner T. Chemotherapy in colorectal cancer. Recommendations of the Norwegian Gastrointestinal Cancer Group. Tidsskr Nor Laegeforen 1996;116: 357–60.
   PubMedGoogle Scholar
• Blomqvist P, Ekbom A, Nyren O, Krusemo U, Bergstrom R, Adami HO. Survival after colon cancer 1973–1990 in Sweden. Convergence between catchment areas. Ann Surg 1997;225:208–16.
   Google Scholar
• Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J. Colon cancer in France: Evidence for improvement in management and survival. Gut 2002;51:60–4.
   PubMed Web of Science ®Google Scholar
• Nedrebø BS, Søreide K, Eriksen MT, Dørum LM, Kvaløy JT, Søreide JA, et al. Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer. Br J Surg 2011;98:716–23.
   PubMed Web of Science ®Google Scholar
• Birgisson H, Talback M, Gunnarsson U, Påhlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005;31:845–53.
   PubMed Web of Science ®Google Scholar
• van Gijn W, Krijnen P, Lemmens VE, den Dulk M, Putter H, van de Velde CJ. Quality assurance in rectal cancer treatment in the Netherlands: A catch up compared to colon cancer treatment. Eur J Surg Oncol 2010;36:340–4.
   PubMed Web of Science ®Google Scholar
• Enblad P, Adami HO, Bergström R, Glimelius B, Krusemo U, Påhlman L. Improved survival of patients with cancers of the colon and rectum?J Natl Cancer Inst 1988;80:586–91.
   PubMedGoogle Scholar
• Mitry E, Bouvier AM, Esteve J, Faivre J. Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 2002;89:1557–62.
   PubMed Web of Science ®Google Scholar
• Engholm G, Kejs AM, Brewster DH, Gaard M, Holmberg L, Hartley R, et al. Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis of 5 year relative period survival in the period 1999 to2000. Int J Cancer2007;121:1115–22.
   Google Scholar
• Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45: 1218–31.
   PubMed Web of Science ®Google Scholar
• Statistics Norway. [cited 17 Jan 2010]. Available from: http://www.ssb.no.
   Google Scholar
• Wibe A, Carlsen E, Dahl O, Tveit KM, Weedon-Fekjaer H, Hestvik UE, et al. Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 2006;8:224–9.
   PubMed Web of Science ®Google Scholar
• Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 2007;94:113–8.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Perme MP, Henderson R, Stare J. An approach to estimation in relative survival regression. Biostatistics 2009;10: 136–46.
   PubMed Web of Science ®Google Scholar
• Perme MP, Stare J, Esteve J. On estimation in relative survival. Biometrics 2012;68:113–20.
   PubMed Web of Science ®Google Scholar
• Pohar M, Stare J. Relative survival analysis in R. Comput Methods Programs Biomed 2006;81:272–8.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Dahl O, Cedermark B, Jakobsen A, Bentzen SM, Starkhammar H, et al. Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol 2005;44:904–12.
   PubMed Web of Science ®Google Scholar
• Dube S, Heyen F, Jenicek M. Adjuvant chemotherapy in colorectal carcinoma: Results of a meta-analysis. Dis Colon Rectum 1997;40:35–41.
   PubMed Web of Science ®Google Scholar
• Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693–701.
   PubMed Web of Science ®Google Scholar
• Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007:CD002102.
   Google Scholar
• Folkesson J, Birgisson H, Påhlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23:5644–50.
   PubMed Web of Science ®Google Scholar
• Sjo OH, Larsen S, Lunde OC, Nesbakken A. Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis 2009;11:733–9.
   PubMed Web of Science ®Google Scholar
• Smedh K, Olsson L, Johansson H, Aberg C, Andersson M. Reduction of postoperative morbidity and mortality in patients with rectal cancer following the introduction of a colorectal unit. Br J Surg 2001;88:273–7.
   PubMed Web of Science ®Google Scholar